Avoid common mistakes on your manuscript.
With great interest we read the recent article by Artzner et al. arguing for a paradigm change in the clinical management of patients with severe acute-on-chronic liver failure (ACLF-3) [1].
We would like to congratulate the authors for their thorough and balanced viewpoint and especially agree with them on the crucial role that critical care needs to have for patients with ACLF-3 in a bridge to early transplantation setting. As support measures, the authors mention the use of renal replacement therapy, vasopressors and mechanical ventilation to stabilize patients in order to enable a window of transplantability.
We would like to raise the question of what critical care physicians might offer these patients beyond basic organ support. Multiorgan failure in ACLF is characterized by excessive systemic inflammation that could represent an additional therapeutic target for extracorporeal strategies. However, their use in ACLF remains controversial as albumin dialysis did not improve short-term survival, neither using the MARS (RELIEF) nor the PROMETHEUS-system (HELIOS) [2].
It might be worth looking beyond ACLF to other diseases with excessive systemic inflammation and multiorgan failure—e.g., septic shock and acute liver failure (ALF).
Therapeutic plasma exchange (TPE) is an extracorporeal strategy utilizing a profoundly different biological approach than the adsorptive strategies, which are all centered at removing injurious mediators. The rationale behind TPE rather follows the idea of combining, such as the removal of excessive injurious mediators with the replacement of diminished protective factors (Table 1) [3].
Our group could demonstrate in patients with septic shock, that TPE effectively removes proinflammatory cytokines, endothelial- and glycocalyx destabilizing factors (e.g., angiopoietin-2, heparanase-1) as well as molecules involved in intravascular clotting and disturbance of the microcirculation (von Willebrand factor antigen, D-dimers) [3]. At the same time, the exchange of septic plasma with that from healthy donors leads to a replenishment of protective but depleted factors involved in anti-inflammatory processes (immunoglobulins), in endothelial stabilization (angiopoietin-1, heparanase-2) and in anti-coagulation (antithrombin-III, protein C, ADAMTS-13) [3]. In a recent trial, additive TPE was associated with rapid hemodynamic improvement in patients with severe refractory septic shock [4]. In ALF, high-volume TPE did not only improve transplant-free survival but also significantly reduced systemic inflammatory response syndrome (SIRS) and multiorgan dysfunction [5].
The APACHE trial is currently ongoing to determine the efficacy and safety of TPE in patients with ACLF (NCT03702920). Although we eagerly await the results, from an intensivist’s point of view the trial design unfortunately has an important shortcoming: human albumin instead of human plasma is used as the replacement fluid, which deprives TPE of the major potential to replace protective factors and, in the worst case, represents a safety issue in the case of already pronounced coagulopathy.
Who, if not intensivists—who are used to care for all organ systems holistically at the same time—should be able to bridge the gap across different critical illness entities such as ACLF, ALF and septic shock to find common ground in establishing more causative stabilization approaches to be offered to our patients?
Availability of data and materials
Not applicable.
References
Artzner T, Fernandez J, Jalan R (2023) Liver transplantation for patients with severe acute on chronic liver failure: it is time to change paradigms. Intensive Care Med. https://doi.org/10.1007/s00134-023-07041-8
Saliba F, Bañares R, Larsen FS, Wilmer A, Parés A, Mitzner S et al (2022) Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts. Intensive Care Med 48(10):1352–1367
Stahl K, Wendel-Garcia PD, Bode C, David S (2022) Unraveling the secret of re-balancing homeostasis in sepsis: a critical view on extracorporeal blood purification modalities. Intensive Care Med 48(1):130–132
David S, Bode C, Putensen C, Welte T, Stahl K (2021) Adjuvant therapeutic plasma exchange in septic shock. Intensive Care Med 47(3):352–354
Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC et al (2016) High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 64(1):69–78
Funding
Open Access funding enabled and organized by Projekt DEAL. No funding was received.
Author information
Authors and Affiliations
Contributions
KS, CB and SD: wrote the manuscript. All the authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
On behalf of all the authors, the corresponding author states that there is no conflict of interest.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available online at https://doi.org/10.1007/s00134-023-07041-8.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Stahl, K., Bode, C. & David, S. Bridging patients with acute-on-chronic liver failure for transplantation: plasma exchange to stabilize multiorgan failure?. Intensive Care Med 49, 890–891 (2023). https://doi.org/10.1007/s00134-023-07092-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-023-07092-x